MedTrace Logo

Clinical Trial to Evaluate ANT-1401 in Crow's Feet

NCT01809964 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2014-01-10

No results posted yet for this study

Summary

The purpose of this study is to confirm the effect of ANT-1401 in the treatment of Lateral Canthal Lines.

Conditions

  • Lateral Canthal Lines
  • Crows Feet

Interventions

BIOLOGICAL

ANT-1401

BIOLOGICAL

Vehicle

Sponsors & Collaborators

  • Anterios Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-06-30
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01809964 on ClinicalTrials.gov